The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Bernhard Witzenbichler
Showing 1-15 of 15 articles
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
Slagboom T,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematus M,
Takahashi A,
Waksman R,
Saito S
January 10, 2023 | 10.4244/EIJ-D-22-00526
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry
Chandrasekhar J,
Baber U,
Sartori S,
Goel R,
Nicolas J,
Vogel B,
Snyder C,
Kini A,
Briguori C,
Witzenbichler B,
Iakovou I,
Sardella G,
Marzo K,
DeFranco A,
Stuckey T,
Chieffo A,
Colombo A,
Shlofmitz R,
Capodanno D,
Dangas G,
Pocock S,
Mehran R
October 7, 2022 | 10.4244/EIJ-D-21-01044
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta S,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz R,
Witzenbichler B,
Kastrati A,
Han Y,
Steg PG,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months
Saito S,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematsu M,
Takahashi A,
Waksman R,
Slagboom T
December 6, 2019 | 10.4244/EIJ-D-18-01214
Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention
Brener S,
Leon M,
Serruys P,
Smits P,
von Birgelen C,
Mehran R,
Kirtane A,
Witzenbichler B,
Rinaldi M,
Metzger C,
Mazzaferri E,
Zhang Z,
Stone G
August 9, 2019 | 10.4244/EIJ-D-19-00262
Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study
Nakatani S,
Onuma Y,
Ishibashi Y,
Karanasos A,
Regar E,
Garcia-Garcia H,
Tamburino C,
Fajadet J,
Vrolix M,
Witzenbichler B,
Eeckhout E,
Spaulding C,
Reczuch K,
La Manna A,
Spaargaren R,
Capodanno D,
van Langenhove G,
Verheye S,
Serruys P,
van Geuns R
December 20, 2015 | 10.4244/EIJY15M11_01
Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry
Toelg R,
Merkely B,
Erglis A,
Hoffmann S,
Bruno H,
Kornowski R,
Slagboom T,
Naber C,
Witzenbichler B,
Graf K,
Richardt G,
Hehrlein C
September 28, 2014 | 10.4244/EIJV10I5A102
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial
Caixeta A,
Lansky A,
Mehran R,
Brener S,
Claessen B,
Généreux P,
Palmerini T,
Witzenbichler B,
Guagliumi G,
Brodie B,
Dudek D,
Fahy M,
Dangas G,
Stone G
June 28, 2013 | 10.4244/EIJV9I2A37
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial
Rakowski T,
Dudek D,
Dziewierz A,
Yu J,
Witzenbichler B,
Guagliumi G,
Kornowski R,
Hartmann F,
Lansky A,
Brener S,
Mehran R,
Stone G
March 22, 2013 | 10.4244/EIJV8I11A199
Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial
Tobbia P,
Brodie B,
Witzenbichler B,
Metzger C,
Guagliumi G,
Yu J,
Kellett M,
Stuckey T,
Fahy M,
Mehran R,
Stone G
February 22, 2013 | 10.4244/EIJV8I10A176
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
Généreux P,
Mehran R,
Palmerini T,
Caixeta A,
Kirtane A,
Lansky A,
Brodie B,
Witzenbichler B,
Mockel M,
Guagliumi G,
Peruga J,
Dudek D,
Fahy M,
Dangas G,
Stone G
December 30, 2011 | 10.4244/EIJV7I8A144
Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions
Verheye S,
Ramcharitar S,
Grube E,
Schofer J,
Witzenbichler B,
Kovac J,
Hauptmann K-E,
Agostoni P,
Wiemer M,
Lefèvre T,
Spaargaren R,
Serruys P,
Garcia-Garcia H,
van Geuns R
September 30, 2011 | 10.4244/EIJV7I5A94
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial
Silber S,
Gutiérrez-Chico J-L,
Behrens S,
Witzenbichler B,
Wiemer M,
Hoffmann S,
Slagboom T,
Harald D,
Suryapranata H,
Nienaber C,
Naber C,
Chevalier B,
Serruys P
May 17, 2011 | 10.4244/EIJV7I1A13
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
Serruys P,
Garg S,
Abizaid A,
Ormiston J,
Windecker S,
Verheye S,
Dubois C,
Stewart J,
Hauptmann K,
Schofer J,
Stangl K,
Witzenbichler B,
Wiemer M,
Barbato E,
de Vries T,
Drijver A-M,
Otake H,
Meredith L,
Toyloy S,
Fitzgerald P
June 30, 2010
First-in-man (FIM) study of the Stentys™ bifurcation stent – 30 days results
Verheye S,
Grube E,
Ramcharitar S,
Schofer J,
Witzenbichler B,
Kovac J,
Hauptmann K-E,
Agostoni P,
Wiemer M,
Lefèvre T,
Serruys P,
van Geuns R
March 20, 2009
1
Latest news
AHEAD OF PRINT
Single antiplatelet therapy directly after PCI
FREE ARTICLE - Niels M.R. van der Sangen et al
February 3, 2023
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke